Epigral Powers Growth with ₹600 Cr Capex Expansion in Dahej

Epigral Ltd. has approved a ₹600 crore capital expenditure (capex) plan to construct a new manufacturing facility at its Dahej site in Gujarat. Scheduled for commercial operations in H2 FY2028, the project will introduce 1,25,000 TPA of capacity for Epoxy Resin and Formulations, alongside a flexible Multi-Purpose Plant (MPP). Funded via internal accruals and debt, this expansion leverages Dahej’s chemical ecosystem to meet growing epoxy demand and solidify Epigral’s footprint in India's specialty chemicals sector.

News by Rahul Yelligetti.